These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 30321467
1. Efficacy of therapeutic plasma exchange on angiotensin II type-1 receptor antibodies on two kidney transplant recipients. Yamada C, Huang Y, Norman S, Naik A, Moussa O, Samaniego M, Cooling L. J Clin Apher; 2018 Dec; 33(6):673-677. PubMed ID: 30321467 [Abstract] [Full Text] [Related]
2. Angiotensin II type-1 receptor antibody (AT1Rab) associated humoral rejection and the effect of peri operative plasma exchange and candesartan. Carroll RP, Riceman M, Hope CM, Zeng A, Deayton S, Bennett GD, Coates PT. Hum Immunol; 2016 Dec; 77(12):1154-1158. PubMed ID: 27542526 [Abstract] [Full Text] [Related]
3. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies. Cuevas E, Arreola-Guerra JM, Hernández-Méndez EA, Salcedo I, Castelán N, Uribe-Uribe NO, Vilatobá M, Contreras-Saldívar AG, Sánchez-Cedillo AI, Ramírez JB, de Rungs D, Granados J, Morales-Buenrostro LE, Alberú J. Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757 [Abstract] [Full Text] [Related]
4. Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients. Yamada C, Ramon DS, Cascalho M, Sung RS, Leichtman AB, Samaniego M, Davenport RD. Transfusion; 2015 Apr; 55(4):727-35; quiz 726. PubMed ID: 25385678 [Abstract] [Full Text] [Related]
5. Pretransplant angiotensin II type 1-receptor antibodies point to an increase in renal graft sub-intimal fibrosis in living- donor kidney transplant recipients. González-Almada A, Arreola-Guerra JM, López-Sánchez JA, Cuevas E, Vilatoba M, Contreras AG, Morales-Buenrostro LE, Alberu J, Uribe-Uribe NO. Transpl Immunol; 2019 Jun; 54():1-8. PubMed ID: 30336216 [Abstract] [Full Text] [Related]
6. Pre-transplant angiotensin II type 1receptor antibodies: a risk factor for decreased kidney graft function in the early post-transplant period? Hernández-Méndez EA, Arreola-Guerra JM, Morales-Buenrostro LE, Ramírez JB, Calleja S, Castelán N, Salcedo I, Vilatobá M, Contreras AG, Gabilondo B, Granados J, Alberú J. Rev Invest Clin; 2014 Jun; 66(3):218-24. PubMed ID: 25695237 [Abstract] [Full Text] [Related]
7. Pre-transplant angiotensin II type 1 receptor antibodies: A risk factor for decreased kidney graft function in the early post-transplant period? Hernández-Méndez EA, Arreola-Guerra JM, Morales-Buenrostro LE, Ramírez JB, Calleja S, Castelán N, Salcedo I, Vilatobá M, Contreras AG, Gabilondo B, Granados J, Alberú J. Clin Transpl; 2013 Jun; ():343-50. PubMed ID: 25095527 [Abstract] [Full Text] [Related]
8. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience. Zheng J, Xue W, Qing X, Jing X, Hou J, Tian X, Guo Q, He X, Cai J. Clin Transpl; 2014 Jun; ():223-30. PubMed ID: 26281149 [Abstract] [Full Text] [Related]
9. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection. Lee H, Kim JI, Moon IS, Chung BH, Yang CW, Kim Y, Han K, Oh EJ. Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439 [Abstract] [Full Text] [Related]
10. Outcome of Pretransplantation Therapeutic Plasma Exchange in Highly Sensitized Deceased-donor Kidney Transplant Recipients. Tipjaiaue P, Ingsathit A, Kantachuvesiri P, Rattanasiri S, Thammanichanond D, Mongkolsuk T, Arpornsujaritkun N, Sumethkul V, Kantachuvesiri S. Transplant Proc; 2017 May; 49(6):1249-1255. PubMed ID: 28735989 [Abstract] [Full Text] [Related]
11. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes. Banasik M, Boratyńska M, Kościelska-Kasprzak K, Kamińska D, Bartoszek D, Zabińska M, Myszka M, Zmonarski S, Protasiewicz M, Nowakowska B, Hałoń A, Chudoba P, Klinger M. Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812 [Abstract] [Full Text] [Related]
14. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients. Zhu D, Qi G, Tang Q, Li L, Yang C, Lin M, Wu B, Xu M, Cai J, Zhu T, Rong R. Clin Transpl; 2014 Oct; ():215-21. PubMed ID: 26281148 [Abstract] [Full Text] [Related]
15. Clinical implications of angiotensin II type 1 receptor antibodies in antibody-mediated rejection without detectable donor-specific HLA antibodies after renal transplantation. Lee J, Park Y, Kim BS, Lee JG, Kim HJ, Kim YS, Huh KH. Transplant Proc; 2015 Apr; 47(3):649-52. PubMed ID: 25891704 [Abstract] [Full Text] [Related]
16. Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient. Guzzo I, Morolli F, Camassei FD, Piazza A, Poggi E, Dello Strologo L. Pediatr Nephrol; 2017 Jan; 32(1):185-188. PubMed ID: 27752765 [Abstract] [Full Text] [Related]
18. C4d-negative antibody-mediated rejection with high anti-angiotensin II type I receptor antibodies in absence of donor-specific antibodies. Fuss A, Hope CM, Deayton S, Bennett GD, Holdsworth R, Carroll RP, Coates PT. Nephrology (Carlton); 2015 Jul; 20(7):467-73. PubMed ID: 25726938 [Abstract] [Full Text] [Related]